Cutaneous T-cell lymphoma: a paradigm for biological therapies

Leukemia & Lymphoma
D A PichardoS T Rosen

Abstract

Mycosis Fungoides and Sézary Syndrome are the most common types of cutaneous T-cell lymphomas. There is no current standard of care for Mycosis Fungoides/Sézary Syndrome, with a general tendency to rely on topical interventions for early disease delaying systemic, more toxic therapy until the development of extensive symptoms. Knowledge of the biological characteristics of this disease has allowed for the development of rational interventions and a significant advance in its treatment. Retinoids are active in Mycosis Fungoides/Sézary Syndrome with the newer rexinoids being available in topical and systemic forms. Interferon alpha remains one of the most active therapeutic agents for Mycosis Fungoides/Sézary Syndrome, especially in combination with other agents such as PUVA. The monoclonal antibody alemtuzumab leads to responses in at least half of patients with advanced disease with its side effect profile consisting mainly of immunosupression and infusion reactions. The recombinant IL2-diphteria toxin denileukin diftitox (Ontak) is active in this disease and appears to have a beneficial effect in symptoms relief and quality of life. Extracorporeal photochemotherapy as an immunostimulating intervention seems to be very effectiv...Continue Reading

References

Sep 1, 1992·Journal of the American Academy of Dermatology·P HealdR Edelson
Apr 1, 1992·American Journal of Clinical Oncology·S ReddyL A Kalasinski
Apr 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F J CummingsM J O'Connell
Feb 7, 1990·Journal of the National Cancer Institute·E H KaplanP A Bunn
Dec 1, 1990·The Journal of Investigative Dermatology·H H RoenigkP A Bunn
Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E C KohnD C Ihde
Feb 1, 1990·American Journal of Clinical Oncology·R SorioS Monfardini
May 1, 1990·Journal of the American Academy of Dermatology·H S ZackheimW R Crain
Jun 1, 1988·The British Journal of Dermatology·K Thestrup-PedersenH Zachariae
Jan 1, 1987·International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement·P A BunnK A Foon
Jul 1, 1988·JAMA : the Journal of the American Medical Association·M A Weinstock, J W Horm
Feb 5, 1987·The New England Journal of Medicine·R EdelsonG Plewig
Jan 1, 1995·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·R Stadler, H G Otte
Aug 1, 1995·Journal of the American Academy of Dermatology·J J HerrmannS T Rosen
Jan 1, 1995·Clinical and Experimental Dermatology·J C SterlingS O Roberts
May 1, 1995·Archives of Dermatology·J P MarolleauC Gisselbrecht
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T M KuzelS T Rosen
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M FossA Bastian
Sep 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P HeskethT Woodworth
Aug 12, 1993·Annals of the New York Academy of Sciences·M ChatterjeeK A Foon
Apr 1, 1996·Journal of the American Academy of Dermatology·H S ZackheimS T Hwang
Oct 31, 1996·Annals of the New York Academy of Sciences·A H RookG Trinchieri
Dec 1, 1996·Journal of the American Academy of Dermatology·J A ZicL E King
Apr 1, 1997·The British Journal of Dermatology·P DrillenburgS T Pals
Jan 1, 1997·Dermatology : International Journal for Clinical and Investigative Dermatology·M T FierroM G Bernengo
Jun 1, 1997·Journal of the American Academy of Dermatology·D GreinerG Petroni
Nov 30, 1999·Photodermatology, Photoimmunology & Photomedicine·S B JiangH W Lim
Jul 25, 2000·The British Journal of Dermatology·E A Coors, P von den Driesch

❮ Previous
Next ❯

Citations

Jun 11, 2010·International Journal of Hematology·Jasmine M Zain, Owen O'Connor
Jan 13, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A SüssJ C Simon
Feb 9, 2012·Current Treatment Options in Oncology·Tara BloomSteven T Rosen
Jun 7, 2006·American Journal of Clinical Pathology·Cynthia M MagroCarl D Morrison
May 3, 2008·Leukemia & Lymphoma·Michael Robert HumphreysVishal Kukreti
Jun 28, 2007·Expert Opinion on Investigational Drugs·Madeleine Duvic, Jenny Vu
Jun 7, 2005·Expert Opinion on Biological Therapy·Jörg Vollmer
Nov 21, 2009·Journal of the American Academy of Dermatology·Jacqueline M Junkins-Hopkins
Dec 11, 2008·The British Journal of Dermatology·N Nieto-RementeríaA Asumendi
Sep 13, 2008·Journal of the American Academy of Nurse Practitioners·Ella Ares
Apr 20, 2007·International Journal of Dermatology·Taku FujimuraSetsuya Aiba
Jan 26, 2010·Actas dermo-sifiliográficas·D S MestelW Sterry
Mar 11, 2005·Expert Review of Anticancer Therapy·John W Eklund, Timothy M Kuzel
Aug 8, 2006·Biotechnology Journal·Theo Dingermann, Ilse Zündorf
Feb 25, 2017·Scientific Reports·Anne SchroederKarsten Gülow
Jul 27, 2005·Pharmazie in unserer Zeit·Ilse ZündorfTheo Dingermann
Oct 24, 2009·Anais Brasileiros De Dermatologia·Renato Soriani PaschoalCacilda da Silva Souza
Jun 20, 2018·Frontiers in Oncology·Kazuyasu Fujii
Apr 10, 2021·International Journal of Dermatology·Natalia Rendón-SernaMaria Bermudez-Muñoz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.